34
Cost-benefit Analysis 1 Abdur Razzaque Sarker MHE (Health Economics), MSS (Economics) Health Economics and Financing Research, icddrb and PhD Fellow in Strathclyde University, UK Email: [email protected]

Cost benifit analysis

Embed Size (px)

Citation preview

Page 1: Cost benifit analysis

1

Cost-benefit Analysis Abdur Razzaque Sarker

MHE (Health Economics), MSS (Economics)Health Economics and Financing Research,

icddrband

PhD Fellow in Strathclyde University, UKEmail: [email protected]

Page 2: Cost benifit analysis

2

What is Cost-Benefit AnalysisCost Benefit Analysis (CBA) is an economic

evaluation technique that both costs and consequences

(benefits) are measured in monetary unit.

Net benefit = Benefits - Costs

Page 3: Cost benifit analysis

3

An intervention should be undertaken if the benefits exceed the costs.

Choose the intervention with the highest net benefit if only one intervention can be funded

Page 4: Cost benifit analysis

4

Why using CBA Resources are limited

The intervention program should be economically viable

CBA adopts a broad societal perspective as it includes all costs and all benefits

Page 5: Cost benifit analysis

5

Economic evaluation methods at a glance

Page 6: Cost benifit analysis

6

Measuring cost of intervention

The cost of intervention will be calculated

in the same way as other economic

evaluation methods (Please see ‘cost

analysis’).

Page 7: Cost benifit analysis

7

Measuring benefits The ways to measure monetary

value of benefits from intervention

1. Cost of illness averted

2. Contingent valuation method (willingness to pay)

Page 8: Cost benifit analysis

8

1. Cost-of-illness averted

The cost of illness (COI) is defined as the value

of the resources that are expended or foregone

as a result of a health problem (like, diseases).

Page 9: Cost benifit analysis

9

Perspectives of COIPatient’s or household’s

perspectiveProvider’s perspectiveSocietal perspective

Page 10: Cost benifit analysis

10

Costs can be classified into three types

Direct Costs: Direct costs related to treating the patients (example, doctor’s visit, drugs, transport)

Indirect Cost: Loss of productivity of patients and care-givers

Intangible cost: Pain, anxiety, discomfort

Page 11: Cost benifit analysis

11

Information needs to be collectedDirect cost How much patients spend for medicine.

How much money was spent for transportation for each visit.

Did you spend any night away from home regarding treatment and spend money to buy food and lodging?

Did you spend any money for any diagnostic tests?

Did you pay consultation fee to the provider?

Page 12: Cost benifit analysis

12

Indirect cost

Examples:

At the time you got sick with cholera, were you employed?

How much time you waited before receiving this service?

What was your daily wage?

How many days had you been absent from work due to illness?

Did anybody take care of you during your illness?

How many days she/he had been absent from work for giving you care?

What was her/his daily wage?

more……

Information needs to be collected

Page 13: Cost benifit analysis

13

Intangible costDifficult to measure and often a limitation of

the study

Information needs to be collected

Page 14: Cost benifit analysis

14

Provider’s actual cost of illnessProvider actual cost of illness will be calculated as the provider’s cost for treatment excluding any fees received from the patients for hospitalization, drug, diagnostic tests etc.

If government implements vaccination against cholera. The cholera hospitals (wards) can be benefited by reducing their cost for treating cholera patients.

Page 15: Cost benifit analysis

15

It includes cost of providers, cost of patients orhouseholds and costs of insurance company (if applicable)

Cost of illness of society

Page 16: Cost benifit analysis

16

The cost of illness that can be averted, i.e.

benefits of the intervention will then be

adjusted for time differentials using

discount rate.

Page 17: Cost benifit analysis

17

Costs Parameters Average cost Standard deviation %of total cost

Direct Medical Diagnostic 9.6 (0.1) 75.7 (1) 9Medicine 148.7 (2) 246 (3.)Registration fee 26.1 (0.3) 130.6 (1.7)Paramedics home visit fee 2.8 (−) 21.5 (0.3)Bed/ Cabin charge 16.9 (0.2) 130.7 (1.7)

Direct Non- Medical

Transportation cost 140 (1.9) 122 (1.6) 15.6food items 63(0.8) 85 (1.1)Informal payment 0.7 (−) 9 (0.1)Caregivers payment 0.1 (−) 1 (−)Materials (mug/glass/coil etc) 10.6(0.1) 17 (0.2)Lodging 28 (0.4) 101 (1.3)Caregivers expenditure 113.2 (1.5) 172 (2.3)

Total direct cost 559.5 (7.4) 641.7 (8.5) 24.6In-direct Patients income loss 811 (11) 4,301 (57)

Caregivers income loss 908 (12.2) 3,701 (49)Total indirect cost 1,719 (23) 5,656 (75.4) 75.4Total cost of illness of household 2,278.5 (30.4) 5,668 (75.6) 100

Average household cost for cholera treatment

Page 18: Cost benifit analysis

18

Suppose in Mirpur area, every year 1200 patients are affected by Cholera diseases and it is estimated by our hospital record. A Cost of illness study conducted and estimate the average cost for treating cholera is $40 from societal perspective. We want to minimized the burden of cholera diseases and he initiated the following three intervention

A Only Vaccination B Vaccination & hand washing technique C Vaccine, hand washing & Water treatment procedure

Page 19: Cost benifit analysis

19

Intervention Total cost (C)Outcome

(No of case averted)

A (Vaccine) 10000 200B ( Vaccine & hand washing) 15000 650C (Vaccine, hand washing and water treatment) 18000 900

We want to know which intervention is sustainable based on cost benefit analysis?

Page 20: Cost benifit analysis

20

Decision tools:

Net Social Benefit (NSB) = B-C

If B > C we take the intervention, i.e. B-C >0, we accepted that program

If B< C i.e. B-C <0, we must rejected that intervention

If B = C , i.e. B-C =0, we are indifferent i.e. it may be accepted or rejected

Page 21: Cost benifit analysis

21

Intervention Total cost (C)Outcome

(No of case averted)

A (Vaccine) 10000 200B ( Vaccine & hand washing) 15000 650C (Vaccine, hand washing and water treatment) 18000 900

Intervention Total cost (C)

Outcome (No of case

averted)Total

Benefit (B)A (Vaccine) 10000 200 8,000B ( Vaccine & hand washing) 15000 650 26,000C (Vaccine, hand washing & Water treatment) 18000 900 36,000Since average COI is $40 for societal perspective

Page 22: Cost benifit analysis

22

Intervention Total cost (C)

Outcome (No of case

averted)

Total Benefit

(B)

Net Social Benefit

(NSB = B-C )

A (Vaccine) 10000 500 8,000 -2,000B ( Vaccine & handwashing) 15000 650 26,000 11000C (Vaccine, hand washing & Water treatment) 18000 900 36,000 18000 If we consider intervention A , here, B – C < 0, Rejected A In intervention B, here, B –C > 0, ie. NSB >0. Accepted BIn intervention C, here, B – C > 0, i,e. NSB >0. Accepted cIf we compare all that program, only one intervention can be funded than alternative C is better, causes it gives higher net social benefit.

Page 23: Cost benifit analysis

23

Assigning Money Values in health outcomes

Human Capital Approaches Cost of illness

Contingent valuation method (CVM)

Willingness-to- Pay (WTP) MethodWillingness –to- Accept (WTP) Method

Page 24: Cost benifit analysis

24

CVM is a direct method which involves asking a sample of the relevant population question about their willingness to pay (WTP) for a certain product (health intervention program)

Willingness to pay (WTP) is the maximum amount aperson would be willing to pay, sacrifice or exchange in order to receive a good or to avoid risk

If individuals answer truthfully, their answers will exactly correspond to the utility change

2. Contingent valuation method (CVM)

Page 25: Cost benifit analysis

25

CV question can be divided into open-ended and discrete choice.

Open-endedUsing bidding game technique

respondents are asked to state their maximum WTP for the benefit of a specific intervention.

Page 26: Cost benifit analysis

26

To introduce the cholera vaccine we asked to all household head to know what they willing to pay (max. WTP) to avoidable this loss (COI).

Did you agree to pay for two doses cholera vaccine Yes…..(1) No….(2)

How much you want to pay for two doses oral Cholera vaccine ?BDT……………………

Page 27: Cost benifit analysis

27

In bidding game (like an auction), respondents are offered with a bid for acceptance or rejection. Depending on respondent’s answer, the bid is then lowered or increased until respondent’s maximum WTP is reached.

We bid a price to household head and know about his WTP which may be increasing or decreasing. And finally we select final WTP.

Page 28: Cost benifit analysis

28

Discrete Respondents are offered a bid and asked

for either accepting or rejecting. Using different bids in different sub-samples, it is possible to calculate the percentage of respondents who are willing to pay as a function of price (bid).

Page 29: Cost benifit analysis

29

Did you agree to pay for two doses cholera vaccine Yes…..(1) No….(2)

If Yes, then which price …

3*2 = 6 USD per family member….....(1)4*2 = 8 USD per family member…….(2)4.5*2= 9 USD per family member…….(3)5*2 =10 USD per family member…….(4)5.5*2 =11 USD per family member…….(5)

Page 30: Cost benifit analysis

30

Survey for contingent valuation

Creating a survey instrument for capturing individuals' WTP

(a) designing the hypothetical scenario;(b) creating a scenario about the means of

payment

Use the survey instrument with a sample of the population of interest

Page 31: Cost benifit analysis

31

Where, i= indexes respondentsY= IncomeE= EducationA = AgeD=disease or health risk exposure experience

WTPi= f (

Yi, Ei, Ai, Di, ... )

Total WTP is achieved by deriving the population average WTP from the data and multiplying it by the population size, N.

Page 32: Cost benifit analysis

32

Note to interviewer:Describe the cholera vaccine, dose and effectiveness both for adult and child to the respondents following the structured description of the product.

Would you be willing to pay X Taka for full vaccination for you?

YesNo

If yes, please explain your reasons for agreeing to pay? 1. The amount is affordable2. I don’t want to suffer from cholera Other, specify ___________

If no, pls explain your reasons for not wanting to pay? 1. Too expensive2. Unable to pay Other, specify ____________

Would you be willing to pay XX Taka for full vaccination for other members of your family?

YesNo

If yes, please explain your reasons for agreeing to pay? 1. The amount is affordable 2. I don’t want to suffer from cholera Other, specify ___________

If no, pls explain your reasons for not wanting to pay? 1. Too expensive2. Unable to pay Other, specify ____________

What would be the maximum amount you would be willing to pay for yourself?

______________________ Tk

What would be the maximum amount you would be willing to pay for other family members?

______________________ Tk

Page 33: Cost benifit analysis

33

Total benefit of the proposed intervention can be calculated by

multiplying average WTP with total number of population in interest group.

Benefits of the intervention (WTP) will then be adjusted for time

differentials using discount rate.

Example,

Total WTP = 10,000 Taka (after discounting)Total cost of intervention = 8,000 Taka (after discounting)Net benefit = 10,000 – 8,000 Taka = 2,000 Taka

Conclusion: If net benefit is higher than zero, then intervention

program is acceptable